Anuh Pharma (BOM:506260) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506260 Anuh Pharma Ltd BOM:506260
86 GF Score
Price ₹83.82
GF Value ₹104.97
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Anuh Pharma FFO per Share?

FFO per Share only applies to REITs.

BOM:506260
86GF Score
Anuh Pharma Ltd BOM:506260
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Anuh Pharma (BOM:506260) Overvalued in 2026?

Based on GuruFocus' analysis, Anuh Pharma stock appears to be undervalued. The current stock price of ₹83.82 is trading 20.1% below its estimated GF Value™ of ₹104.97. GuruFocus considers Anuh Pharma to be Modestly Undervalued.

Key valuation signals for BOM:506260:

  • FFO per Share:
  • GF Value™: ₹104.97 vs. price of ₹83.82 (20.1% below fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the BOM:506260 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Anuh Pharma Business Description

Other Exchanges ANUHPHR:India
Address Dr. Annie Besant Road, North Wing, 3-A, Shiv Sagar Estate, Worli, Mumbai, MH, IND, 400 018
Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.
86GF Score

Get the complete analysis for BOM:506260

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹83.82
Price
₹104.97
GF Value